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Ischemia/reperfusion injury (IRI) and organ failure, espe-
cially IRI-induced remote and multiple organ failure, con-
tribute significantly to postoperativemortality andmorbidity,
and reperfusion induced oxidative stress plays a critical role
in this pathology. Postoperative mortality risk increases in
aged patients and in patients with concomitant diseases like
diabetes which itself is associated with increased oxidative
stress. Given that people now live longer and are often with
concomitant diseases, IRI in these population is more severe
and prevention or treatment of IRI will be an increasing
important area of intention.
Ischemic heart disease is a major complication of dia-
betes [1, 2]. Although expeditious percutaneous coronary
intervention can restore coronary flow and limit myocardial
infarction, reperfusion may also cause cardiac damage—
“ischemia/reperfusion injury (IRI)” [3]. Diabetic heart is
more vulnerable to IRI [4, 5] but less sensitive to percuta-
neous coronary intervention and ischemic pre- or postcon-
ditioning cardioprotection, and the underlying mechanism
remains unclear. In this special issue, Y. Zhao et al. reported
that acute hyperglycemia not only exacerbated myocardial
IRI but completely abolished the cardioprotective effect of
ischemic preconditioning by inhibiting Akt phosphorylation
and disrupting signaling pathways downstream of adenosine
A
1
receptor but not adenosine A
1
receptor activation itself.
Interestingly, insulin treatment to normalize blood glucose
levels could restore the cardioprotective effects of ischemic
preconditioning, despite that insulin failed to counteract the
detrimental effect of hyperglycemia. This is an interesting
area that deserves further exploration. Further, M. Liu et al.
reported that hyperglycemia-induced inhibition of myocar-
dial DJ-1 protein expression may represent one of the major
mechanisms why hearts of diabetic subjects are less or not
responsive to ischemic postconditioning cardioprotection.
Remote ischemic preconditioning has recently been
shown to effectively attenuate myocardial ischemia/ reperfu-
sion injury in patients [6, 7], but the underlying mechanisms
are incompletely understood. In this special issue, T. Pang
et al. performed remote ischemic preconditioning in healthy
volunteers and conducted comprehensive proteomic analysis
in order to identify the mechanisms. Furthermore, X. Qiao et
al. reported that transient acidosis during early reperfusion
canmimic the cardioprotective effects of ischemic postcondi-
tioning in a rat model of myocardial IRI induced by coronary
artery occlusion/reperfusion. These studies, among others,
are significant advancement in the study of ischemic pre- and
postconditioning cardioprotection.
Reactive oxygen species (ROS) induced vascular
endothelial dysfunction plays an important role in
the development of IRI in various organs. In this special
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issue, J. Wang et al. reported that endothelial progenitor cell-
derived microvesicles (EPC-MVs) can promote angiogenesis
of endothelial cells and attenuate hypoxia/reoxygenation
injury in human brain microvascular endothelial cells.
Further, S. Ma et al. reported that the application of low
frequency pulse magnetic fields can effectively reduce ROS
generation and subsequently attenuate myocardial IRI. Their
finding that low frequency pulsemagnetic fields could protect
the myocardium against IRI via regulating ROS generation
and nitric oxide/peroxynitrite balance is a very novel finding
that may have high potential to serve as a promising strategy
for combating cardiac IRI. X. Zhang et al. reported that
Resolvin D1 can effectively protect against impairment of
endothelial barrier function induced by lipopolysaccharide
in human vascular endothelial cells. This finding may be
of significant clinical relevance given that during IRI the
increased production of proinflammatory cytokines such as
tumor necrosis factor-𝛼 (TNF-𝛼) further increases oxidative
stress and exacerbate reperfusion injury [8]. The paper
by S. Lei et al. in this special issue reported that TNF-𝛼
stimulation in endothelial cells can induce oxidative stress
primarily through protein kinase C (PKC)-𝛽
2
dependent
NADPH oxidase activation and reduce vascular endothelial
cell viability.
The intravenous anesthetic propofol possesses antiox-
idant capacity and has been shown to attenuate IRI in
patients undergoing cardiac surgery [9] and in animal
models of IRI [10]. However, the mechanisms by which
propofol confers protective effects against IRI has not been
fully elucidated. In this special issue, Z. Chen et al. sys-
tematically analyzed the alterations in microRNA expres-
sion in human umbilical vein endothelial cells subjected
to hypoxia/reoxygenation in the presence or absence of
posthypoxic propofol treatment and provided genome-wide
profiling of microRNAs assessed using microRNA microar-
ray.
The experimental therapeutic studies regarding the neu-
roprotective effect and mechanisms of Ginkgolide B on cell
injury reported by L. Li et al. and the effect of safflower
yellow on spinal cord IRI reported by D. Zhou et al. are all
of potential clinical implications.
The review article by C. Nastos et al. reviewed the existing
literature regarding the proposed mechanisms of remote
organ injury after liver ischemia and reperfusion.This review
brings to our attention the important issue of liver IRI-
induced remote organ injuries [11, 12].
We hope that the original and review articles presented
in this special issue, representing the current advances in the
oxidative stress-mediated ischemia-reperfusion injury, with
respect to their potential impact in cellular survival pathways
and therapeutic strategies, will stimulate further exploration
of this important area.
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